127 related articles for article (PubMed ID: 28515387)
1. Functional polymorphisms affecting Th1 differentiation are associated with the severity of autoimmune thyroid diseases.
Inoue N; Watanabe M; Nakaguchi A; Ueda D; Kawaguti H; Hidaka Y; Iwatani Y
Endocr J; 2017 Jul; 64(7):695-703. PubMed ID: 28515387
[TBL] [Abstract][Full Text] [Related]
2. The polymorphisms in the thyroid peroxidase gene were associated with the development of autoimmune thyroid disease and the serum levels of anti-thyroid peroxidase antibody.
Tomari S; Watanabe M; Inoue N; Mizuma T; Yamanaka C; Hidaka Y; Iwatani Y
Endocr J; 2017 Oct; 64(10):1025-1032. PubMed ID: 28845025
[TBL] [Abstract][Full Text] [Related]
3. TSHR Gene Polymorphisms in the Enhancer Regions Are Most Strongly Associated with the Development of Graves' Disease, Especially Intractable Disease, and of Hashimoto's Disease.
Fujii A; Inoue N; Watanabe M; Kawakami C; Hidaka Y; Hayashizaki Y; Iwatani Y
Thyroid; 2017 Jan; 27(1):111-119. PubMed ID: 27762730
[TBL] [Abstract][Full Text] [Related]
4. Association of the polymorphisms in the gene encoding thyroglobulin with the development and prognosis of autoimmune thyroid disease.
Mizuma T; Watanabe M; Inoue N; Arakawa Y; Tomari S; Hidaka Y; Iwatani Y
Autoimmunity; 2017 Sep; 50(6):386-392. PubMed ID: 28675712
[TBL] [Abstract][Full Text] [Related]
5. Gene polymorphisms of VEGF and VEGFR2 are associated with the severity of Hashimoto's disease and the intractability of Graves' disease, respectively.
Okamoto M; Watanabe M; Inoue N; Ogawa K; Hidaka Y; Iwatani Y
Endocr J; 2020 May; 67(5):545-559. PubMed ID: 32074519
[TBL] [Abstract][Full Text] [Related]
6. Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease.
Nanba T; Watanabe M; Inoue N; Iwatani Y
Thyroid; 2009 May; 19(5):495-501. PubMed ID: 19415997
[TBL] [Abstract][Full Text] [Related]
7. Association of functional polymorphisms related to the transcriptional level of FOXP3 with prognosis of autoimmune thyroid diseases.
Inoue N; Watanabe M; Morita M; Tomizawa R; Akamizu T; Tatsumi K; Hidaka Y; Iwatani Y
Clin Exp Immunol; 2010 Dec; 162(3):402-6. PubMed ID: 20942809
[TBL] [Abstract][Full Text] [Related]
8. Involvement of functional polymorphisms in the TNFA gene in the pathogenesis of autoimmune thyroid diseases and production of anti-thyrotropin receptor antibody.
Inoue N; Watanabe M; Nanba T; Wada M; Akamizu T; Iwatani Y
Clin Exp Immunol; 2009 May; 156(2):199-204. PubMed ID: 19250279
[TBL] [Abstract][Full Text] [Related]
9. IL-10 -592A/C polymorphism is associated with severity of Hashimoto's disease.
Inoue N; Watanabe M; Wada M; Morita M; Hidaka Y; Iwatani Y
Cytokine; 2013 Oct; 64(1):370-4. PubMed ID: 23757290
[TBL] [Abstract][Full Text] [Related]
10. The IL15 +96522 A>T functional polymorphism is related to the differentiation of Th17 cells and the severity of Hashimoto's disease.
Arakawa Y; Watanabe M; Takemura K; Inoue N; Hidaka Y; Iwatani Y
Int J Immunogenet; 2017 Apr; 44(2):41-50. PubMed ID: 28164472
[TBL] [Abstract][Full Text] [Related]
11. Association of the polymorphisms of chemokine genes (IL8, RANTES, MIG, IP10, MCP1 and IL16) with the pathogenesis of autoimmune thyroid diseases.
Akahane M; Watanabe M; Inoue N; Miyahara Y; Arakawa Y; Inoue Y; Katsumata Y; Hidaka Y; Iwatani Y
Autoimmunity; 2016 Aug; 49(5):312-9. PubMed ID: 27245471
[TBL] [Abstract][Full Text] [Related]
12. Association of functional polymorphisms in promoter regions of IL5, IL6 and IL13 genes with development and prognosis of autoimmune thyroid diseases.
Inoue N; Watanabe M; Morita M; Tatusmi K; Hidaka Y; Akamizu T; Iwatani Y
Clin Exp Immunol; 2011 Mar; 163(3):318-23. PubMed ID: 21235536
[TBL] [Abstract][Full Text] [Related]
13. Association of
Hirai N; Watanabe M; Inoue N; Kinoshita R; Ohtani H; Hidaka Y; Iwatani Y
Autoimmunity; 2019; 52(7-8):251-255. PubMed ID: 31552761
[TBL] [Abstract][Full Text] [Related]
14. DICER and DROSHA gene expression and polymorphisms in autoimmune thyroid diseases.
Saeki M; Watanabe M; Inoue N; Tokiyoshi E; Takuse Y; Arakawa Y; Hidaka Y; Iwatani Y
Autoimmunity; 2016 Dec; 49(8):514-522. PubMed ID: 27808570
[TBL] [Abstract][Full Text] [Related]
15. Associations of single nucleotide polymorphisms in precursor-microRNA (miR)-125a and the expression of mature miR-125a with the development and prognosis of autoimmune thyroid diseases.
Inoue Y; Watanabe M; Inoue N; Kagawa T; Shibutani S; Otsu H; Saeki M; Takuse Y; Hidaka Y; Iwatani Y
Clin Exp Immunol; 2014 Nov; 178(2):229-35. PubMed ID: 24990808
[TBL] [Abstract][Full Text] [Related]
16. Functional Polymorphisms of the Type 1 and Type 2 Iodothyronine Deiodinase Genes in Autoimmune Thyroid Diseases.
Inoue N; Watanabe M; Katsumata Y; Ishido N; Hidaka Y; Iwatani Y
Immunol Invest; 2018 Jul; 47(5):534-542. PubMed ID: 29648895
[TBL] [Abstract][Full Text] [Related]
17. Association of the polymorphisms in Th2 chemotaxis-related genes with the development and prognosis of autoimmune thyroid diseases.
Omori N; Watanabe M; Inoue N; Taniguchi J; Hidaka Y; Iwatani Y
Endocr J; 2018 Aug; 65(8):815-826. PubMed ID: 29848886
[TBL] [Abstract][Full Text] [Related]
18. Associations between autoimmune thyroid disease prognosis and functional polymorphisms of susceptibility genes, CTLA4, PTPN22, CD40, FCRL3, and ZFAT, previously revealed in genome-wide association studies.
Inoue N; Watanabe M; Yamada H; Takemura K; Hayashi F; Yamakawa N; Akahane M; Shimizuishi Y; Hidaka Y; Iwatani Y
J Clin Immunol; 2012 Dec; 32(6):1243-52. PubMed ID: 22706687
[TBL] [Abstract][Full Text] [Related]
19. Association between functional SIRT1 polymorphisms and the clinical characteristics of patients with autoimmune thyroid disease.
Sarumaru M; Watanabe M; Inoue N; Hisamoto Y; Morita E; Arakawa Y; Hidaka Y; Iwatani Y
Autoimmunity; 2016 Aug; 49(5):329-37. PubMed ID: 27245255
[TBL] [Abstract][Full Text] [Related]
20. Association of the -31C/T functional polymorphism in the interleukin-1beta gene with the intractability of Graves' disease and the proportion of T helper type 17 cells.
Hayashi F; Watanabe M; Nanba T; Inoue N; Akamizu T; Iwatani Y
Clin Exp Immunol; 2009 Dec; 158(3):281-6. PubMed ID: 19793334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
